Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

SOPHiA GENETICS (SOPH) Revenue (2020 - 2025)

SOPHiA GENETICS's Revenue history spans 6 years, with the latest figure at $21.7 million for Q4 2025.

  • On a quarterly basis, Revenue rose 22.41% to $21.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $77.3 million, a 18.56% increase, with the full-year FY2025 number at $77.3 million, up 18.56% from a year prior.
  • Revenue hit $21.7 million in Q4 2025 for SOPHiA GENETICS, up from $19.5 million in the prior quarter.
  • Over the last five years, Revenue for SOPH hit a ceiling of $21.7 million in Q4 2025 and a floor of $9.0 million in Q1 2021.
  • Historically, Revenue has averaged $14.6 million across 5 years, with a median of $15.4 million in 2023.
  • Biggest five-year swings in Revenue: plummeted 99.86% in 2021 and later skyrocketed 39.96% in 2023.
  • Tracing SOPH's Revenue over 5 years: stood at $10.9 million in 2021, then grew by 22.37% to $13.4 million in 2022, then grew by 27.38% to $17.0 million in 2023, then grew by 4.02% to $17.7 million in 2024, then increased by 22.41% to $21.7 million in 2025.
  • Business Quant data shows Revenue for SOPH at $21.7 million in Q4 2025, $19.5 million in Q3 2025, and $18.3 million in Q2 2025.